Inhibition of lipopolysaccharide-stimulated TNF-α promoter activity by S-adenosylmethionine and 5′-methylthioadenosine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 2 50-2, 2004, Pages

  Veal, Nary ^a,c   Hsieh, Chih Lin ^d   Xiong, Shigang ^a,c   Mato, Jose M ^e   Lu, Shelly ^a,b   Tsukamoto, Hidekazu ^a,b,c,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Department of Pathology ^*  (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CIC BIOGUNE   (Spain)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Kupffer cells; Macrophages; Nuclear factor B

Indexed keywords

5' METHYLTHIOADENOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN P300; S ADENOSYLMETHIONINE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISEASE MODEL; DNA METHYLATION; GENE OVEREXPRESSION; INHIBITION KINETICS; KUPFFER CELL; LIVER DISEASE; LIVER PROTECTION; MACROPHAGE ACTIVATION; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DEOXYADENOSINES; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; E1A-ASSOCIATED P300 PROTEIN; KUPFFER CELLS; LIPOPOLYSACCHARIDES; METHIONINE; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-ARGININE N-METHYLTRANSFERASE; RATS; RATS, WISTAR; RNA, MESSENGER; S-ADENOSYLMETHIONINE; THIONUCLEOSIDES; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242671568     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00316.2003     Document Type: Article

References (48)

1. Ansorena E, Garcia-Trevijano ER, Martinez-Chantar ML, Huang ZZ, Chen L, Mato JM, Iraburu M, Lu SC, and Avila MA. S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 35: 274-280, 2002.
2. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, and Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 168: 6404-6411, 2002.
3. Blazka ME, Elwell MR, Holladay SD, Wilson RE, and Luster MI. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 24: 181-189, 1996.
4. Bogdan C, Paik J, Vodovotz Y, and Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 267: 23301-23308, 1992.
5. Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, and Ulevitch RJ. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J Clin Invest 102: 1645-1652, 1998.
6. Bradham CA, Plumpe J, Manns MP, Brenner DA, and Trautwein C. Mechanisms of Hepatic Toxicity. I. TNF-induced liver injury. Am J Physiol Gastrointest Liver Physiol 275: G387-G392, 1998.
7. Bray GP, Tredger JM, and Williams R. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology 15: 297-301, 1992.
8. Brown CY, Lagnado CA, Vadas MA, and Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem 271: 20108-20112, 1996.
9. Caboche M and Hatzfeld J. Methionine metabolism in BHK cells: preliminary characterization of the physiological effects of cycloleucine, an inhibitor of S-adenosylmethionine biosynthesis. J Cell Physiol 97: 361-370, 1978.
10. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, and McClain CJ. S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol 275: G125-G129, 1998.
11. Chevillard-Briet M, Trouche D, and Vandel L. Control of CBP coactivating activity by arginine methylation. EMBO J 21: 5457-5466, 2002.
12. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
13. Collart MA, Baeuerle P, and Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 10: 1498-1506, 1990.
14. Corrales F, Gimenez A, Alvarez L, Caballeria J, Pajares MA, Andreu H, Pares A, Mato JM, and Rodes J. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 16: 1022-1027, 1992.
15. Dante R, Arnaud M, and Niveleau A. Effects of 5′deoxy-5′- methylthioadenosine on the metabolism of S-adenosylmethionine. Biochem Biophys Res Commun 114: 214-221, 1983.
16. Denys A, Udalova IA, Smith C, Williams LM, Ciesielski CJ, Campbell J, Andrews C, Kwaitkowski D, and Foxwell BM. Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages. J Immunol 168: 4837-4845, 2002.
17. Dokka S, Shi X, Leonard S, Wang L, Castranova V, and Rojanasakul Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol 280: L1196-L1202, 2001.
18. Drouet C, Shakhov AN, and Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol 147: 1694-1700, 1991.
19. Eloranta TO and Kajander EO. Catabolism and lability of S-adenosyl-L-methionine in rat liver extracts. Biochem J 224: 137-144, 1984.
20. Feo F, Pascale R, Garcea R, Daino L, Pirisi L, Frassetto S, Ruggiu ME, Di Padova C, and Stramentinoli G. Effect of the variations of S-adenosyl-L- methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxicol Appl Pharmacol 83: 331-341, 1986.
21. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, and Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94: 2927-2932, 1997.
22. Han J, Huez G, and Beutler B. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J Immunol 146: 1843-1848, 1991.
23. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369, 1967.
24. Iimuro Y, Gallucci RM, Luster MI, Kono H, and Thurman RG. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26: 1530-1537, 1997.
25. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, and Benkirane M. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766, 2003.
26. Latasa MU, Boukaba A, Garcia-Trevijano ER, Torres L, Rodriguez JL, Caballeria J, Lu SC, Lopez-Rodas G, Franco L, Mato JM, and Avila MA. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration. FASEB J 15: 1248-1250, 2001.
27. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, Sasaki R, and Leo MA. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165-172, 1990.
28. Lin M, Rippe RA, Niemela O, Brittenham G, and Tsukamoto H. Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol Gastrointest Liver Physiol 272: G1355-G1364, 1997.
29. McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, and Barve S. S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 27: 185-192, 2002.
30. Muiznieks I and Doerfler W. The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: a comparative study. FEBS Lett 344: 251-254, 1994.
31. Pascale RM, Simile MM, Satta G, Seddaiu MA, Daino L, Pinna G, Vinci MA, Gaspa L, and Feo F. Comparative effects of L-methionine, S-adenosyl-L-methionine and 5′-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis. Anticancer Res 11: 1617-1624, 1991.
32. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, and Nabel GJ. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523-527, 1997.
33. Ratter F, Gassner C, Shatrov V, and Lehmann V. Modulation of tumor necrosis factor-alpha-mediated cytotoxicity by changes of the cellular methylation state: mechanism and in vivo relevance. Int Immunol 11: 519-527, 1999.
34. Schreiber E, Matthias P, Muller MM, and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
35. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, and Jongeneel CV. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171: 35-47, 1990.
36. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, and Collins T. Transcriptional activation by NF-κB requires multiple coactivators. Mol Cell Biol 19: 6367-6378, 1999.
37. Simile MM, Banni S, Angioni E, Carta G, De Miglio MR, Muroni MR, Calvisi DF, Carru A, Pascale RM, and Feo F. 5′-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication. J Hepatol 34: 386-394, 2001.
38. Takahashi N, Tetsuka T, Uranishi H, and Okamoto T. Inhibition of the NF-κB transcriptional activity by protein kinase A. Eur J Biochem 269: 4559-4565, 2002.
39. Torczynski R, Bollon AP, and Fuke M. The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res 11: 4879-4890, 1983.
40. Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, and Brittenham G. Iron primes hepatic macrophages for NF-κB activation in alcoholic liver injury. Am J Physiol Gastrointest Liver Physiol 277: G1240-G1250, 1999.
41. Varela-Moreiras G, Alonso-Aperte E, Rubio M, Gasso M, Deulofeu R, Alvarez L, Caballeria J, Rodes J, and Mato JM. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment. Hepatology 22: 1310-1315, 1995.
42. Wang P, Wu P, Siegel MI, Egan RW, and Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153: 811-816, 1994.
43. Watson WH, Zhao Y, and Chawla RK. S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J 342: 21-25, 1999.
44. Wu SE, Huskey WP, Borchardt RT, and Schowen RL. Chiral instability at sulfur of S-adenosylmethionine. Biochemistry 22: 2828-2832, 1983.
45. Xu W, Chen H, Du K, Asahara H, Tini M, Emerson BM, Montminy M, and Evans RM. A transcriptional switch mediated by cofactor methylation. Science 294: 2507-2511, 2001.
46. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, and Thurman RG. Essential rote of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117: 942-952, 1999.
47. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.
48. Zuckerman SH, Evans GF, and Guthrie L. Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology 73: 460-465, 1991.